Mathematical modeling of cancer treatment with radiation and PD-L1 inhibitor
基本信息来源于合作网站,原文需代理用户跳转至来源网站获取
摘要:
Radiation therapy is a longstanding cancer treatment.More recently,it has been demonstrated that radiation therapy (RT) elicits anti-cancer immune response.For this reason,there is a growing interest in combining RT with immunotherapy,specifically with checkpoint inhibitors such as anti-CTLA-4 and anti-PD-L1.In the present paper,we develop a mathematical model of combination therapy with RT and anti-PD-L1.The model is used to compare different schedules in clinical trials.Simulations of the model show that applying both RT and anti-PD-L1 at the same week has more benefits than applying them in separate adjacent weeks.Furthermore,applying anti-PD-L1 before RT has more benefits than applying RT before anti-PD-L1.